Home › Companies › VENTYX BIOSCIENCES INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and VENTYX BIOSCIENCES INC.’s Form 8-K, filed June 6, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 5, 2024: 4 items on VENTYX BIOSCIENCES INC.’s Form 8-K, filed June 6, 2024: 2 elected · 2 approved.
Significant dissent: 1 director (25.4% against).
Notable dissent: 1 say-on-pay vote (76.7% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore VENTYX BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are VENTYX BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Onaiza Cadoret-Manier, M.B.A. | 32,008,430 | -- | -- | 10,875,159 | 14,526,548 | 75% | Elected | — |
| Elect Director: Allison Hulme, Ph.D. | 42,643,275 | -- | -- | 250,371 | 14,516,491 | 99.4% | Elected | — |
| 2. Advisory Vote on Executive Compensation. The "say-on-pay" proposal regarding the compensation of our named executive officers as described on page 21 of the Proxy Statement | 32,870,217 | 10,004,898 | 18,529 | -- | 14,516,493 | 77% | Approved | — |
| 4. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 | 56,542,563 | 119,328 | 748,246 | -- | -- | 99.8% | Approved | — |
Source: VENTYX BIOSCIENCES INC., Form 8-K, filed with the SEC on June 6, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
135 asset managers disclosed a vote on at least one VENTYX BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VENTYX BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Allison Hulme, Ph.D.
VENTYX BIOSCIENCES INC.’s own tally for this item (“Elect Director: Allison Hulme, Ph.D.”): 42,643,275 for, 250,371 withheld, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our common stock to serve as our Class III directors to hold office until our 2027 annual meeting of stockholders and until their successors have been duly elected and qualified:”
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 8,328,843 for, 77,584 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,314,190 | 0 | 0 | 0 | For |
| Capital Group | 1,561,616 | 0 | 0 | 0 | For |
| BlackRock | 1,065,788 | 0 | 0 | 0 | For |
| Fidelity | 966,794 | 0 | 0 | 0 | For |
| JPMorgan | 525,558 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 430,000 | 0 | 0 | 0 | For |
| Charles Schwab | 385,155 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 202,500 | 0 | 0 | 0 | For |
| Equitable | 61,163 | 0 | 0 | 73,530 | Mixed |
| TIAA | 132,656 | 0 | 0 | 0 | For |
| Lincoln Financial | 117,027 | 0 | 0 | 1,006 | For |
| Voya | 93,469 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 91,731 | 0 | 0 | 0 | For |
| Invesco | 88,141 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 49,062 | 0 | 0 | 0 | For |
| New York Life | 45,508 | 0 | 0 | 0 | For |
| T. Rowe Price | 21,396 | 0 | 0 | 0 | For |
| Northern Trust | 21,135 | 0 | 0 | 0 | For |
| State Street | 18,738 | 0 | 0 | 0 | For |
| John Hancock | 17,181 | 0 | 0 | 0 | For |
| Brighthouse | 15,792 | 0 | 0 | 0 | For |
| Pacific Life | 15,115 | 0 | 0 | 0 | For |
| Nationwide | 13,060 | 0 | 0 | 0 | For |
| SEI | 9,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,711 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Description as filed by funds: To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Onaiza Cadoret Manier, M.B.A.
VENTYX BIOSCIENCES INC.’s own tally for this item (“Elect Director: Onaiza Cadoret-Manier, M.B.A.”): 32,008,430 for, 10,875,159 withheld, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our common stock to serve as our Class III directors to hold office until our 2027 annual meeting of stockholders and until their successors have been duly elected and qualified:”
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 40 asset managers below reported 7,145,036 for, 1,058,891 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,300,590 | 0 | 0 | 13,600 | For |
| Capital Group | 1,561,616 | 0 | 0 | 0 | For |
| BlackRock | 1,065,788 | 0 | 0 | 0 | For |
| Fidelity | 962,794 | 0 | 0 | 4,000 | For |
| JPMorgan | 525,558 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 430,000 | Withhold |
| Charles Schwab | 385,155 | 0 | 0 | 0 | For |
| Equitable | 61,163 | 0 | 0 | 73,530 | Mixed |
| TIAA | 0 | 0 | 0 | 132,656 | Withhold |
| Lincoln Financial | 100,240 | 0 | 0 | 17,793 | Mixed |
| Voya | 0 | 0 | 0 | 93,469 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 91,731 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 88,141 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 49,062 | Withhold |
| New York Life | 0 | 0 | 0 | 45,508 | Withhold |
| T. Rowe Price | 21,396 | 0 | 0 | 0 | For |
| Northern Trust | 21,135 | 0 | 0 | 0 | For |
| State Street | 18,738 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 17,181 | Withhold |
| Brighthouse | 0 | 0 | 0 | 15,792 | Withhold |
| Pacific Life | 15,115 | 0 | 0 | 0 | For |
| Nationwide | 0 | 0 | 0 | 13,060 | Withhold |
| SEI | 0 | 0 | 0 | 9,300 | Withhold |
| Bridge Builder Trust | 8,711 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 8,024 | Withhold |
Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
77% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote").
VENTYX BIOSCIENCES INC.’s own tally for this item (“2. Advisory Vote on Executive Compensation. The "say-on-pay" proposal regarding the compensation of our named executive officers as described on page 21 of the Proxy Statement”): 32,870,217 for, 10,004,898 against — passed, per its Form 8-K filed June 6, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The "say-on-pay" proposal regarding the compensation of our named executive officers as described on page 21 of the Proxy Statement was approved, on an advisory basis.”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,314,190 | 0 | 0 | 0 | For |
| Capital Group | 0 | 1,561,616 | 0 | 0 | Against |
| BlackRock | 1,065,788 | 0 | 0 | 0 | For |
| Fidelity | 966,794 | 0 | 0 | 0 | For |
| JPMorgan | 525,558 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 430,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 385,155 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 202,500 | 0 | 0 | 0 | For |
| Equitable | 134,693 | 0 | 0 | 0 | For |
| TIAA | 132,656 | 0 | 0 | 0 | For |
| Lincoln Financial | 117,027 | 1,006 | 0 | 0 | For |
| Voya | 93,469 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 91,731 | 0 | 0 | 0 | For |
| Invesco | 0 | 88,141 | 0 | 0 | Against |
| AIG/SunAmerica | 49,062 | 0 | 0 | 0 | For |
| New York Life | 45,508 | 0 | 0 | 0 | For |
| T. Rowe Price | 21,396 | 0 | 0 | 0 | For |
| Northern Trust | 21,135 | 0 | 0 | 0 | For |
| State Street | 18,738 | 0 | 0 | 0 | For |
| John Hancock | 17,181 | 0 | 0 | 0 | For |
| Brighthouse | 15,792 | 0 | 0 | 0 | For |
| Pacific Life | 15,115 | 0 | 0 | 0 | For |
| Nationwide | 12,330 | 730 | 0 | 0 | Mixed |
| SEI | 0 | 9,300 | 0 | 0 | Against |
| Bridge Builder Trust | 8,711 | 0 | 0 | 0 | For |
Fund voting reports, all 41 managers: 6,344,467 for, 2,061,960 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,665,485 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 0 | 2,164,126 | 0 | 0 | Against |
| ORBIMED ADVISORS LLC | 0 | 1,870,456 | 0 | 0 | Against |
| Citadel | 1,682,899 | 0 | 0 | 0 | For |
| Capital Group | 7,619 | 1,561,616 | 0 | 0 | Against |
| BlackRock | 1,537,820 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 1,501,114 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 1,420,000 | 0 | 0 | 0 | For |
| Opaleye Management Inc. | 1,245,000 | 0 | 0 | 0 | For |
| Point72 | 1,213,436 | 0 | 0 | 0 | For |
| State Street | 863,864 | 299 | 0 | 0 | For |
| JPMorgan | 811,956 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 772,136 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 678,178 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 430,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 385,155 | 0 | 0 | Against |
| FARALLON CAPITAL MANAGEMENT LLC | 0 | 380,000 | 0 | 0 | Against |
| Northern Trust | 372,743 | 56 | 0 | 0 | For |
| Fidelity | 352,160 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 286,687 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 198,335 | 0 | 0 | 0 | For |
| DE Shaw | 147,312 | 0 | 0 | 0 | For |
| UBS | 137,482 | 80 | 0 | 0 | For |
| Nuveen | 134,044 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 125,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 109 managers: 18,421,287 for, 6,892,885 against, 1,787 abstained, 1,375 not voted, 24,727 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.9% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Delaware/Macquarie | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| MUTUAL FUND SERIES TRUST | 202,500 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| New York Life | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 41 managers: 202,500 for, 8,199,873 1 year, 4,054 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0 | 0 | 0 | 0 | -- |
| Redmile Group, LLC | 0 | 0 | 0 | 0 | -- |
| ORBIMED ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Octagon Capital Advisors LP | 0 | 0 | 0 | 0 | -- |
| Cormorant Asset Management, LP | 0 | 0 | 0 | 0 | -- |
| Point72 | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| FARALLON CAPITAL MANAGEMENT LLC | 380,000 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| UBS | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| First Light Asset Management, LLC | 125,000 | 0 | 0 | 0 | For |
| OMERS ADMINISTRATION Corp | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| HighTower Advisors, LLC | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 104 managers: 529,868 for, 25 against, 1,375 not voted, 22,067,124 1 year, 5,452 3 year, 2,254 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Prior year: 100.0% for (June 7, 2023 meeting) ▼ 0.2 pts
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.
VENTYX BIOSCIENCES INC.’s own tally for this item (“4. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024”): 56,542,563 for, 119,328 against — passed, per its Form 8-K filed June 6, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal was approved, on an advisory basis, of the board of directors recommendation that the advisory vote on the compensation of our named executive officers be submitted to our stockholders every one year as discussed in page 23 of the Proxy Statement.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 8,406,427 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,314,190 | 0 | 0 | 0 | For |
| Capital Group | 1,561,616 | 0 | 0 | 0 | For |
| BlackRock | 1,065,788 | 0 | 0 | 0 | For |
| Fidelity | 966,794 | 0 | 0 | 0 | For |
| JPMorgan | 525,558 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 430,000 | 0 | 0 | 0 | For |
| Charles Schwab | 385,155 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 202,500 | 0 | 0 | 0 | For |
| Equitable | 134,693 | 0 | 0 | 0 | For |
| TIAA | 132,656 | 0 | 0 | 0 | For |
| Lincoln Financial | 118,033 | 0 | 0 | 0 | For |
| Voya | 93,469 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 91,731 | 0 | 0 | 0 | For |
| Invesco | 88,141 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 49,062 | 0 | 0 | 0 | For |
| New York Life | 45,508 | 0 | 0 | 0 | For |
| T. Rowe Price | 21,396 | 0 | 0 | 0 | For |
| Northern Trust | 21,135 | 0 | 0 | 0 | For |
| State Street | 18,738 | 0 | 0 | 0 | For |
| John Hancock | 17,181 | 0 | 0 | 0 | For |
| Brighthouse | 15,792 | 0 | 0 | 0 | For |
| Pacific Life | 15,115 | 0 | 0 | 0 | For |
| Nationwide | 13,060 | 0 | 0 | 0 | For |
| SEI | 9,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,711 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 70,499,332 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.28% |
| 2 | Capital Group | 2.22% |
| 3 | BlackRock | 1.51% |
| 4 | Fidelity | 1.37% |
| 5 | JPMorgan | 0.75% |
| 6 | Delaware/Macquarie | 0.61% |
| 7 | Charles Schwab | 0.55% |
| 8 | MUTUAL FUND SERIES TRUST | 0.29% |
| 9 | Equitable | 0.19% |
| 10 | TIAA | 0.19% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5.20% |
| 2 | Redmile Group, LLC | 3.07% |
| 3 | ORBIMED ADVISORS LLC | 2.65% |
| 4 | Citadel | 2.39% |
| 5 | Capital Group | 2.23% |
| 6 | BlackRock | 2.18% |
| 7 | Octagon Capital Advisors LP | 2.13% |
| 8 | Cormorant Asset Management, LP | 2.01% |
| 9 | Opaleye Management Inc. | 1.77% |
| 10 | Point72 | 1.72% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Somasundaram Subramaniam, M.B.A. | 8,477,397 | 12.02% | Proxy statement (DEF 14A), table as of April 11, 2024 |
| Entities affiliated with New Science Ventures | 8,439,635 | 11.97% | Proxy statement (DEF 14A), table as of April 11, 2024 |
| S | 6,715,501 | 9.53% | Schedule 13G, filed November 14, 2024 |
| Citadel Advisors | 5,972,592 | 8.47% | Form 13F, quarter ended March 31, 2024 |
| Entities affiliated with Citadel Advisors LLC | 4,279,553 | 6.07% | Proxy statement (DEF 14A), table as of April 11, 2024 |
| Vanguard Group | 3,769,997 | 5.35% | Form 13F, quarter ended March 31, 2024 |
| Cormorant Global Healthcare Master Fund, LP | 3,670,000 | 5.21% | Proxy statement (DEF 14A), table as of April 11, 2024 |
| Deerfield Partners, L.P. | 3,542,000 | 5.02% | Proxy statement (DEF 14A), table as of April 11, 2024 |
| Point72 | 2,531,002 | 3.59% | Form 13F, quarter ended March 31, 2024 |
| Raju Mohan, Ph.D. | 2,508,473 | 3.56% | Proxy statement (DEF 14A), table as of April 11, 2024 |
Percentages above are of 70,499,332 shares outstanding, as reported by VENTYX BIOSCIENCES INC. on its Form 10-Q dated May 6, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At VENTYX BIOSCIENCES INC.'s shareholder meeting held June 5, 2024, in the 2023-2024 proxy season, 135 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 953 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the named executive officers identified… — VENTYX BIOSCIENCES INC.'s filing reports the proposal as approved, with 77% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VENTYX BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VENTYX BIOSCIENCES INC.’s 10-Q dated May 6, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
VENTYX BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “VENTYX BIOSCIENCES INC. 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/ventyx-biosciences-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.